Example by Inspectorate for Handling Temperature Excursions
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
In a recent blog of the Medicines and Healthcare products Regulatory Agency (MHRA), the inspectorate looks at one aspect of the new Annex 16 - the handling of unexpected deviations.
In the blog, MHRA is illustrating its opinion with an example of a short-term temperature excursion during the transport of a product from a third country to the EU:
"The label claim for the product is 'store below 25°C', and the excursion was up to 29°C for 3 days. Existing stability data demonstrated no issues when stored at 30°C for up to 3 months. This situation would fall within the scope of 'unexpected deviations', provided that the shipment process was designed to comply with the registered conditions (i.e. that the excursion could be reasonably described as 'unexpected')." That does mean that the Qualified Person (QP) would be in a position to certify the batch.
However, MHRA states, "if there were no controls over shipment conditions, then the use of stability data as a 'routine' means to justify such an excursion would not be acceptable."
To find out more please see the MHRA nspectorate's blog "Handling of unexpected deviations".
Related GMP News
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting
18.06.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 4
18.06.2026GDP Non-Compliance Report: Missed CAPA Timelines lead to Refusal of GDP Certificate
17.06.2026European GDP Association Developments January through April 2026
12.05.2026How Are Service Providers Qualified in a GDP Environment?
12.05.2026Questions and Answers from the ECA Webinar "GDP Update 2026" - Part 3


